연구동향 분석
박사

한방병원 입원 4기 암환자들의 CRP, ESR, Fibrinogen 수치 변화와 치료기간과의 상관관계 분석 : 후향적 차트리뷰 : Correlation of Inflammation and Coagulation Markers with the Treatment Period of Stage IV Cancer Inpatients in a Korean Medicine Hospital:A Retrospective Chart Review

전형준 2015년

논문상세정보
인용/피인용
' 한방병원 입원 4기 암환자들의 CRP, ESR, Fibrinogen 수치 변화와 치료기간과의 상관관계 분석 : 후향적 차트리뷰 : Correlation of Inflammation and Coagulation Markers with the Treatment Period of Stage IV Cancer Inpatients in a Korean Medicine Hospital:A Retrospective Chart Review' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • crp
  • esr
  • fibrinogen
  • stable state
  • treatment period
  • wheel balanced cancer therapy
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
121 0

0.0%

' 한방병원 입원 4기 암환자들의 CRP, ESR, Fibrinogen 수치 변화와 치료기간과의 상관관계 분석 : 후향적 차트리뷰 : Correlation of Inflammation and Coagulation Markers with the Treatment Period of Stage IV Cancer Inpatients in a Korean Medicine Hospital:A Retrospective Chart Review' 의 참고문헌

  • http://www.nlm.nih.gov/medlineplus/ency/article/003650.htm. Accessed on Oct. 24 2014.
  • Walsh D, Mahmoud F, Barna B. Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Supportive care in cancer 2003;11(1):60-62.
  • Tibble* JA, Sigthorsson* G, Bridger* S, Fagerhol‡ MK, Bjarnason* I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119(1):15-22.
  • Tang L, Liu K, Wang J, Wang C, Zhao P, Liu J. High preoperative plasma fibrinogen levels are associated with distant metastases and impaired prognosis after curative resection in patients with colorectal cancer. J Surg Oncol 2010;102(5):428-432.
  • Shu X, McCulloch M, Xiao H, Broffman M, Gao J. Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Integr Cancer Ther 2005 Sep;4(3):219-229.
  • Sengupta S, Lohse CM, Cheville JC, Leibovich BC, Thompson RH, Webster WS, et al. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. Cancer 2006;106(2):304-312.
  • Seebacher V, Polterauer S, Grimm C, Husslein H, Leipold H, Hefler-Frischmuth K, et al. The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial. Br J Cancer 2010;102(6):952-956.
  • Scott H, McMillan D, Forrest L, Brown D, McArdle C, Milroy R. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 2002;87(3):264-267.
  • Robertson J, Pearson D, Price M, Selby C, Pearson J, Blamey R, et al. Prospective assessment of the role of five tumour markers in breast cancer. Cancer Immunology, Immunotherapy 1991;33(6):403-410.
  • Polterauer S, Grimm C, Seebacher V, Concin N, Marth C, Tomovski C, et al. Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study. Oncologist 2009 Oct;14(10):979-985.
  • Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 2009 Jul 20;27(21):3437-3444.
  • Park HM, Kim SY, Jung IC, Lee YW, Cho CK, Yoo HS. Integrative tumor board: a case report and discussion from East-West Cancer Center. Integr Cancer Ther 2010 Jun;9(2):236-245.
  • Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 2005 Jan 1;105(1):178-185.
  • Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 2000 Nov 15;96(10):3302-3309.
  • Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. The American journal of surgery 2001;182(2):197-201.
  • Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998 Oct;176(4):335-338.
  • Ning S, Jiang B, Xu L, Fang T, Wu M. Effect of Liangxuehuayu Recipe on hemorheology in rats with blood stasis syndrome. Asian Pacific journal of tropical medicine 2012;5(12):935-938.
  • Monreal M, Lafoz E, Casals A, Inaraja L, Montserrat E, Callejas JM, et al. Occult cancer in patients with deep venous thrombosis. A systematic approach. Cancer 1991;67(2):541-545.
  • McMillan DC, Elahi MM, Sattar N,Angerson WJ, Johnstone J, McArdle CS. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 2001;41(1-2):64-69.
  • Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 2005 Sep 1;23(25):6240-6248.
  • Liu L, Duan J, Tang Y, Guo J, Yang N, Ma H, et al. Taoren?Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation. J Ethnopharmacol 2012;139(2):381-387.
  • Kodama J, Miyagi Y, Seki N, Tokumo K, Yoshinouchi M, Kobashi Y, et al. Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1999 Jan;82(1):107-110.
  • Johansson J, Sigurdsson T, Holmberg L, Bergstrom R. Erythrocyte sedimentation rate as a tumor marker in human prostatic cancer. An analysis of prognostic factors in 300 population?based consecutive cases. Cancer 1992;70(6):1556-1563.
  • Jeungwon Y, Chong-Kwan C, Ji-Eun S, Hwa-Seung Y. Changes in the Laboratory Data for Cancer Patients Treated with Korean-medicine-based Inpatient Care. Journal of Pharmacopuncture 2014;17(1):20-26.
  • Henry-Amar M, Friedman S, Hayat M, Somers R, Meerwaldt JH, Carde P, et al. Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. Ann Intern Med 1991;114(5):361-365.
  • Hefler LA, Concin N, Hofstetter G, Marth C, Mustea A, Sehouli J, et al. Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res 2008 Feb 1;14(3):710-714.
  • Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M, Kawasaki K, et al. The impact of preoperative serum C?reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 2005;103(9):1856-1864.
  • Gislason T, Nou E. Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: an epidemiological study. Eur J Respir Dis 1985 Feb;66(2):141-146.
  • Foss S, Kramar A, Droz J. Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-α. Eur J Cancer 1994;30(9):1310-1314.
  • Ford ES. Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am J Epidemiol 2002 Jan 1;155(1):57-64.
  • Encan T, Hannisdal E. Blood analyses as prognostic factors in primary lung cancer. Acta Oncol 1990;29(2):151-154.
  • Crumley AB, McMillan DC, McKernan M, Going JJ, Shearer CJ, Stuart RC. An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer 2006 Jun 5;94(11):1568-1571.
  • Barber MD, Ross JA, Fearon KC. Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer 1999;35(2):106-110.
  • Alexandrakis M, Passam F, Ganotakis E, Sfiridaki K, Xilouri I, Perisinakis K, et al. The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin?6 (IL?6) and acute phase protein levels in multiple myeloma. Clinical & Laboratory Haematology 2003;25(1):41-46.
  • ?1. Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, Kim BG, et al. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer 2009 May 20;9:155-2407-9-155.